Fundraising Fox
/Companies
Sign in

Nostopharma

Potomac, US · Maryland LLC · 2 known investors

Find your way into Nostopharma

Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.

BiotechHealthtechMedical Devices

Founders & leadership

EV
Ekaterina Vert-WongNamed on SEC filing
JG
Jelena Gvozdenovic-JeremicNamed on SEC filing

Investors · 2

TEDCOlisted by TEDCOColumbia

How we know: press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$500K disclosed across 2 rounds · 2023–2024

▶$250KraisedSep 2024 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ekaterina Vert-WongExecutive Officer, Director
  • Jelena Gvozdenovic-JeremicExecutive Officer
Offering amount
$250K
Amount sold
$250K
First sale
Sep 2024
Incorporated
Limited Liability Company, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJun 2023 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Ekaterina Vert-WongExecutive Officer, Director
  • Jelena JeremicExecutive Officer, Director
Offering amount
$250K
Amount sold
$250K
First sale
Jun 2023
Incorporated
Limited Liability Company, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

TEDCO Invests in Nostopharma | citybizcitybiz.co · Jan 2025Nostopharma Using LSN and RESI Navigate A Seed Roundblog.lifesciencenation.com · Jun 2020NCC-PDI Announces Finalists in $250K Pediatric Pitch Competition - WFMJ.com News weather sports for Youngstown-Warren Ohiowfmj.com · Apr 2019

Frequently asked questions

What does Nostopharma do?
Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.
Who are Nostopharma's investors?
Nostopharma's investors include Maryland TEDCO, TEDCO.
How much funding has Nostopharma raised?
Nostopharma has disclosed $500K raised across 2 rounds.
Where is Nostopharma headquartered?
Nostopharma is headquartered in Potomac, US.